|
Bone Density Conservation Agents
|
D050071 |
[Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS.
] |
|
Bone Development
|
D001846 |
[The growth and development of bones from fetus to adult. It includes two principal mechanisms of bone growth: growth in length of long bones at the epiphyseal cartilages and growth in thickness by depositing new bone (OSTEOGENESIS) with the actions of OSTEOBLASTS and OSTEOCLASTS.
] |
|
Bone Diseases
|
D001847 |
[Diseases of BONES.
] |
|
Bone Diseases, Developmental
|
D001848 |
[Diseases resulting in abnormal GROWTH or abnormal MORPHOGENESIS of BONES.
] |
|
Bone Diseases, Endocrine
|
D001849 |
[Diseases of the bones related to hyperfunction or hypofunction of the endocrine glands.
] |
|
Bone Diseases, Infectious
|
D001850 |
[Bone diseases caused by pathogenic microorganisms.
] |
|
Bone Diseases, Metabolic
|
D001851 |
[Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
] |
|
Bone Lengthening
|
D001852 |
[Increase in the longest dimension of a bone to correct anatomical deficiencies, congenital, traumatic, or as a result of disease. The lengthening is not restricted to long bones. The usual surgical methods are internal fixation and distraction.
] |
|
Bone Malalignment
|
D017760 |
[Displacement of bones out of line in relation to joints. It may be congenital or traumatic in origin.
] |
|
Bone Marrow
|
D001853 |
[The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells.
] |
|
Bone Marrow Cells
|
D001854 |
[Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells.
] |
|
Bone Marrow Diseases
|
D001855 |
[Diseases involving the BONE MARROW.
] |
|
Bone Marrow Examination
|
D001856 |
[Removal of bone marrow and evaluation of its histologic picture.
] |
|
Bone Marrow Failure Disorders
|
D000080983 |
[Inherited or acquired diseases characterized by insufficient and/or dysplastic blood cells.
] |
|
Bone Marrow Neoplasms
|
D019046 |
[Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as MULTIPLE MYELOMA. Most bone marrow neoplasms are metastatic.
] |
|
Bone Marrow Purging
|
D016465 |
[Techniques for the removal of subpopulations of cells (usually residual tumor cells) from the bone marrow ex vivo before it is infused. The purging is achieved by a variety of agents including pharmacologic agents, biophysical agents (laser photoirradiation or radioisotopes) and immunologic agents. Bone marrow purging is used in both autologous and allogeneic BONE MARROW TRANSPLANTATION.
] |
|
Bone Marrow Stromal Antigen 2
|
D000074010 |
[A GPI-linked membrane glycoprotein and antiviral factor that functions as a homodimer. It is induced by INTERFERON-GAMMA and blocks the release of enveloped mammalian viruses by directly tethering nascent VIRAL PARTICLES to the membranes of infected cells.
] |
|
Bone Marrow Transplantation
|
D016026 |
[The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION.
] |
|
Bone Matrix
|
D001857 |
[Extracellular substance of bone tissue consisting of COLLAGEN fibers, ground substance, and inorganic crystalline minerals and salts.
] |
|
Bone Morphogenetic Protein 1
|
D055395 |
[A bone morphogenetic protein family member that includes an active tolloid-like metalloproteinase domain. The metalloproteinase activity of bone morphogenetic protein 1 is specific for the removal of the C-propeptide of PROCOLLAGEN and may act as a regulator of EXTRACELLULAR MATRIX deposition. Alternative splicing of MRNA for bone morphogenetic protein 1 results in the production of several PROTEIN ISOFORMS.
] |
